agilon health (NYSE:AGL) Trading 9.6% Higher – Here’s Why

agilon health, inc. (NYSE:AGL) rose 9.6% on Friday . The company traded as high as $2.12 and last traded at $2.11. Approximately 2,120,714 shares traded hands during trading, an increase of 16% from the average daily volume of 1,826,953 shares. The stock had previously closed at $1.92.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. Macquarie initiated coverage on agilon health in a report on Monday, December 16th. They issued a “neutral” rating and a $3.00 price objective for the company. Royal Bank of Canada restated an “outperform” rating and issued a $3.00 price objective on shares of agilon health in a research report on Tuesday, November 19th. Citigroup decreased their target price on shares of agilon health from $2.50 to $1.75 and set a “sell” rating for the company in a research note on Wednesday, November 13th. Bank of America lowered shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price target on the stock. in a research report on Wednesday, October 2nd. Finally, Sanford C. Bernstein initiated coverage on shares of agilon health in a research report on Wednesday, December 11th. They issued a “market perform” rating and a $2.50 price objective for the company. Three investment analysts have rated the stock with a sell rating, sixteen have given a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $4.28.

agilon health Trading Up 10.4 %

The company has a 50 day moving average of $2.11 and a 200 day moving average of $3.95. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The stock has a market capitalization of $873.48 million, a price-to-earnings ratio of -2.26 and a beta of 0.51.

agilon health (NYSE:AGL) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The business had revenue of $1.45 billion during the quarter, compared to analysts’ expectations of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same period in the prior year, the business posted ($0.06) earnings per share. On average, research analysts predict that agilon health, inc. will post -0.52 EPS for the current fiscal year.

Insider Activity

In other news, Director Karen Mcloughlin acquired 25,000 shares of the business’s stock in a transaction that occurred on Friday, December 13th. The stock was purchased at an average cost of $2.20 per share, for a total transaction of $55,000.00. Following the completion of the transaction, the director now owns 73,166 shares in the company, valued at approximately $160,965.20. This trade represents a 51.90 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director John William Wulf bought 45,000 shares of the firm’s stock in a transaction on Thursday, December 5th. The stock was purchased at an average price of $2.18 per share, for a total transaction of $98,100.00. Following the completion of the acquisition, the director now directly owns 206,133 shares in the company, valued at $449,369.94. The trade was a 27.93 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased 90,000 shares of company stock worth $198,100 over the last ninety days. Corporate insiders own 3.20% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Citigroup Inc. boosted its stake in agilon health by 2,251.5% during the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after buying an additional 1,941,993 shares during the period. AQR Capital Management LLC boosted its position in shares of agilon health by 3,338.5% during the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after purchasing an additional 1,316,990 shares during the period. JPMorgan Chase & Co. increased its holdings in agilon health by 326.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock valued at $5,563,000 after purchasing an additional 1,083,492 shares during the last quarter. Quantbot Technologies LP purchased a new stake in agilon health in the third quarter valued at approximately $1,742,000. Finally, Susquehanna Fundamental Investments LLC lifted its stake in agilon health by 65.0% during the second quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock worth $5,262,000 after purchasing an additional 316,856 shares in the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.